MedPath

Quit IT: Preliminary Testing of a Web-based, 3D Coping Skills Game to Increase Quitting Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization

Not Applicable
Completed
Conditions
Tobacco Use Cessation
Registration Number
NCT02099097
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to develop and test a web-based game called Quit It that is designed to help smokers who have quit smoking cope with any smoking urges they may have. The purpose of the game is to help people quit and stop people from smoking again.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age ≥ 18 years old
  • English-speaking
  • Cancer (solid tumor) diagnosis or mass suspicious of cancer within past six months as per clinical judgment
  • Cancer treatment expected plan to include hospitalization for surgical treatment for at least 2 days at MSKCC as per the patients clinical team
  • Referred to MSK's Tobacco Cessation Program
  • Patient-reported cigarette use within the past 30 days
  • Have sufficient sensory acuity (i.e., auditory, visual) and manual dexterity to use a computer game as per judgment of clinician or consenting professional
  • Can be reached by telephone
Exclusion Criteria
  • Distant metastatic disease at the time of enrollment
  • Major psychiatric illness or cognitive impairment that in the judgment of the investigator would preclude study participation
  • Any patients who are unable to comply with the study procedures as determined by the study investigators

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
quitting smoking self-efficacy1 year

as measured by the Confidence Questionnaire to assess changes in confidence in being able to resist urges to smoke across everyday situations.

Secondary Outcome Measures
NameTimeMethod
efficacy of the game1 year

on smoking abstinence and relapse prevention. We will examine time to smoking relapse following hospitalization, measured as part of the follow-up Smoking Status 1 month following enrollment. We will also biochemically verify 7-day point prevalence smoking abstinence at the 1 month follow-up assessment.

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.